MedPath
HSA Approval

PANADOL MINI CAPS CAPSULE 500MG

SIN16479P

PANADOL MINI CAPS CAPSULE 500MG

PANADOL MINI CAPS CAPSULE 500MG

April 19, 2022

GSK CONSUMER HEALTHCARE SINGAPORE PTE. LTD.

GSK CONSUMER HEALTHCARE SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGSK CONSUMER HEALTHCARE SINGAPORE PTE. LTD.
Licence HolderGSK CONSUMER HEALTHCARE SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

CAPSULE

ORAL

Medical Information

N02BE01

paracetamol

Manufacturer Information

gsk consumer healthcare singapore pte. ltd.

Granules India Limited

Granules India Limited (DP Intermediate)

Active Ingredients

Paracetamol

500mg

Acetaminophen

Documents

Patient Information Leaflets

Panadol Mini Caps Capsules 500mg PIL.pdf

Approved: April 19, 2022

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.